z-logo
open-access-imgOpen Access
The first family with adult osteogenesis imperfecta caused by a novel homozygous mutation in CREB3L1
Author(s) -
Cayami Ferdy K.,
Maugeri Alessandra,
Treurniet Sanne,
Setijowati Eva D.,
Teunissen Bernd P.,
Eekhoff Elisabeth M.W.,
Pals Gerard,
Faradz Sultana M.,
Micha Dimitra
Publication year - 2019
Publication title -
molecular genetics and genomic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.765
H-Index - 29
ISSN - 2324-9269
DOI - 10.1002/mgg3.823
Subject(s) - medicine , osteogenesis imperfecta , compound heterozygosity , dentinogenesis imperfecta , mutation , genetics , pathology , gene , biology
Abstract Background Osteogenesis imperfecta (OI) is a clinically heterogeneous disease characterized by extreme skeletal fragility. It is caused by mutations in genes frequently affecting collagen biosynthesis. Mutations in CREB3L1 encoding the ER stress transducer OASIS are very rare and are only reported in pediatric patients. We report a large family with a novel CREB3L1 mutation, with severe adult clinical presentation. Methods Clinical examination was performed on the family members. Next generation sequencing was performed for the causative genes for OI. The mutation was confirmed in other family members with Sanger sequencing. Results A novel homozygous mutation in CREB3L1 was identified in the three affected patients. The parents and siblings who carry the mutation in heterozygous state were clinically unaffected. The three affected siblings, who were reported to have been born healthy, presented very severe progressive skeletal malformations and joint contractures but absence of common OI characteristics including blue sclerae, deafness, and dentinogenesis imperfecta. Resorption of a part of the humerus presumably associated with fracture nonunion and pseudarthrosis. Conclusion We report a novel homozygous CREB3L1 mutation in a large Indonesian family; the homozygous affected members have survived to adulthood and they present a more severe phenotype than previously reported, expanding the clinical spectrum of OI for this gene.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here